Tuberculosis Clinical Trial
Official title:
Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi
Verified date | March 2020 |
Source | Dignitas International |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Task shifting of less complex healthcare tasks to lay health workers (LHWs) is increasingly
employed strategy to address the global shortage of skilled health workers. Despite
availability of effective treatment, tuberculosis (TB) remains an important cause of
mortality with 1.3 million lives lost globally to TB in 2012. The greatest proportion of new
TB cases occurs in Africa and over 95% of TB deaths occur in low income countries (LICs). In
response to the combined high TB burden and severe healthcare worker shortages in these
settings, outpatient TB care is among the tasks commonly shifted to LHWs.
LHWs are community members who have received some training but are not healthcare
professionals. Randomised trials show LHWs improve access to basic health services and TB
treatment outcomes, however, insufficient training and supervision are recognized barriers to
their effectiveness.
The investigators' goal is to improve TB care provided by LHWs in Malawi by implementing and
evaluating a knowledge translation (KT) strategy designed to facilitate incorporation of
evidence into LHW practice. The investigators will employ a mixed methods design including a
pragmatic cluster randomized controlled trial to evaluate effectiveness of the strategy and
qualitative methods to understand barriers and facilitators to scalability and sustainability
of the program.
Status | Completed |
Enrollment | 1153 |
Est. completion date | February 2018 |
Est. primary completion date | February 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - all health centers in participating districts that routinely provide TB care will be included. - LHWs who have received the intervention and patients receiving care at participating health centers will be eligible to participate in interviews Exclusion Criteria: - health centers that do not routinely provide TB care - LHWs unwilling or unable to give informed consent. - TB patients less than 18 years of age unaccompanied by a parent or guardian, patients/guardians or LHWs unwilling or unable to give informed consent, patients presenting to a health center they are not routinely followed at. |
Country | Name | City | State |
---|---|---|---|
Malawi | 4 Districts, SE zone of Malawi (Balaka, Machinga, Mangochi, Mulanje) | Malawi |
Lead Sponsor | Collaborator |
---|---|
Dignitas International | St. Michael's Hospital, Toronto |
Malawi,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of Cases Successfully Treated, Defined as the Total Number of Cases Cured and Completing Treatment. | primary outcome =proportion of cases successfully treated, defined as the total number of cases cured and completing treatment. | 1 year | |
Secondary | Proportion of Default Cases (Treatment Interrupted >= 2 Consecutive Months) | secondary outcome =proportion of default cases (treatment interrupted >= 2 consecutive months) | 1 year | |
Secondary | Proportion of Successes Among HIV Co-infected Cases | secondary outcome = proportion of successes among HIV co-infected cases | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05738681 -
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05526885 -
Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa
|
N/A | |
Completed |
NCT04369326 -
Community Initiated Preventive Therapy for TB
|
N/A | |
Recruiting |
NCT04568967 -
TB-CAPT EXULTANT - HIV
|
N/A | |
Completed |
NCT02337270 -
Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol
|
Phase 1 | |
Not yet recruiting |
NCT06253715 -
Shortened Regimen for Drug-susceptible TB in Children
|
Phase 3 | |
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Withdrawn |
NCT03639038 -
Tuberculosis Diagnosis by Flow Cytometry
|
||
Completed |
NCT03199313 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
|
Phase 1 | |
Recruiting |
NCT04975178 -
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
|
Phase 3 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03973970 -
Assessing the Ability of the T-SPOT®.TB Test (IQ)
|
||
Recruiting |
NCT04230395 -
Alcohol Reduction Among People With TB and HIV in India
|
N/A | |
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Active, not recruiting |
NCT02906007 -
Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05917210 -
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
|
N/A | |
Not yet recruiting |
NCT05845112 -
Start Taking Action For TB Diagnosis
|
||
Not yet recruiting |
NCT06017843 -
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
|
N/A | |
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT02781909 -
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis
|
Phase 2 |